Introduction
============

Within the last decade it has become increasingly clear that small RNAs (sRNAs) are equally efficient and versatile regulators of gene expression as protein-based transcription factors. Most *trans*-encoded sRNAs act at the post-transcriptional level by base-pairing to target mRNAs and can have a positive or negative effect on gene expression by affecting translation and/or RNA decay.[@R1]^,^[@R2] Small RNAs typically offer only limited complementarity to their targets. A segment of only seven contiguous bases, the so-called seed region, can be sufficient to confer specificity.[@R3]^-^[@R5] Therefore, sRNAs are well suited for regulation of multiple mRNAs. Another level of complexity is reached when a single mRNA is subject to regulation by several sRNAs.[@R6] Overall, this can lead to large sRNA-based regulatory networks that sense and respond to the nutritional status of the cell.[@R7]^,^[@R8]

The fundamental importance of sRNAs is reflected by their involvement in numerous cellular processes, like cell division (DicF), transcription (6S RNA), photosynthesis (PcrZ), stress adaption (OxyS), virulence, quorum sensing (Qrr), carbon storage (CsrBC), and phosphosugar metabolism.[@R9]^-^[@R21] A class of genes frequently controlled by sRNAs codes for periplasmic substrate binding proteins of bacterial ABC transporters.[@R7]^,^[@R22]^-^[@R26] This transporter superfamily uses periplasmic solute-binding proteins to take up a wide range of substrates (sugars, amino acids and their derivatives, as well as proteins and drugs).[@R27]^-^[@R29]

Most of our knowledge on sRNAs derives from studies with *Escherichia coli* and *Salmonella*. However, deep sequencing-assisted approaches have revealed numerous sRNAs in any given bacterium or archaeon.[@R30] Experimental evidence for a regulatory function of these small-sized RNAs has been provided in a limited number of cases, for example, in *Bacillus subtilis* and other Gram-positives, in cyanobacteria, archaea, *Rhodobacter*, and *Xanthomonas*.[@R11]^,^[@R31]^-^[@R35]

Genome-wide surveys have recently revealed hundreds of sRNAs in the plant pathogen *Agrobacterium tumefaciens*.[@R36]^,^[@R37] This bacterium is able to induce tumors (crown galls) upon transfer of a DNA fragment (T-DNA) from its tumor-inducing (Ti) plasmid to the nuclear genome of the host plant.[@R38]^,^[@R39] In the transformed plant cells, expression of T-DNA encoded growth factor genes results in cell proliferation and tumor formation. Additionally, plant metabolism is re-programmed to produce opines serving as carbon and nitrogen source for *A*. *tumefaciens*.[@R40]^,^[@R41] Perception of plant-derived signals involves several bacterial factors, including the two-component system VirA/VirG, which mediates the activation of the virulence cascade, and ChvE, a periplasmic substrate binding protein that binds host-derived sugars and plays a role in activation of the virulence cascade (ChvE).[@R42]^-^[@R45] Other putative substrate-binding proteins are involved in attachment (AttC), host defense (Atu2422 and Atu4243), and agrocinopine uptake.[@R46]^-^[@R49] In addition to these specialized functions in plant-microbe interaction, ABC transport systems are required for regular nutrient acquisition in *A*. *tumefaciens* like in other free-living bacteria.[@R50]

At least three ABC transporters in *A. tumefaciens* are under negative control of the sRNA AbcR1 (ABC transporter regulator 1).[@R26] Among the targets is *atu2422* encoding the binding protein for GABA (γ-amino butyric acid), a plant-derived defense molecule that interferes with quorum sensing in *Agrobacterium*.[@R47]^,^[@R51] AbcR1 is encoded in an intergenic region in tandem with the related sRNA AbcR2.[@R26] Both are maximally expressed in the late exponential phase. Currently, there is no evidence that AbcR2 plays a regulatory role in *A. tumefaciens*.

Like *Agrobacterium*, various *Rhizobium* species encode numerous sRNAs, including homologs of AbcR1 and AbcR2.[@R52]^-^[@R56] In contrast to *Agrobacterium*, AbcR1 and AbcR2 in *Sinorhizobium* are divergently expressed, namely the first is present in exponential phase whereas the second accumulates in stationary phase suggesting that they operate at different conditions.[@R57] The amino acid binding protein LivK was found to be controlled by AbcR1 but not AbcR2.[@R57] Two other ABC transporter genes are negatively regulated by AbcR1 and AbcR2.[@R58] In *Brucella abortus*, both AbcR1 and AbcR2 seem to have at least some redundant function.[@R59] Microarray analysis revealed about 25 elevated transcripts, several coding for ABC transporters, in the double mutant. At least three of these transcripts can be controlled by AbcR1 or AbcR2 alone. Moreover, only the double mutant but neither single mutant was attenuated in macrophages and in mice. The commonalities and differences in AbcR1-mediated gene regulation in these model organisms certainly warrants further studies to understand the role of this conserved sRNA in a plant pathogen, a plant symbiont, and a human pathogen.

AbcR1 belongs to the large group of Hfq-associated sRNAs.[@R55]^,^[@R59]^-^[@R61] Hfq is an RNA chaperone that facilitates base-pairing between sRNAs and their targets.[@R62]^,^[@R63] About 10 ABC transporter proteins were found to accumulate in an *A. tumefaciens* ∆*hfq* mutant and we wondered whether more than the previously identified three targets *atu2422*, *atu1879*, and *frcC* were controlled by AbcR1.[@R26]^,^[@R61] We used a combination of proteomics and bioinformatics approaches to identify numerous new targets of AbcR1. RNA--RNA interactions studies revealed that AbcR1 uses two separate regions to address mRNAs either in the translation initiation region (TIR) or far downstream in the coding region. Our results support the function of AbcR1 as versatile master regulator to control *Agrobacterium* physiology.

Results
=======

AbcR1 regulates periplasmic binding proteins of several ABC transporters
------------------------------------------------------------------------

To identify new targets of AbcR1, we compared the proteomes of the marker-less AbcR1 mutant (∆AbcR1) and the wild-type (WT) strain by two-dimensional PAGE. Cultures were grown to stationary phase (OD600 of 1.5) when AbcR1 is maximally expressed.[@R26] Total protein extracts from three biological replicates were subjected to two-dimensional PAGE and the relative protein abundance was visualized by dual-channel images ([Fig. S1](#SUP1){ref-type="supplementary-material"}). Proteins equally abundant in the WT and mutant appear as yellow spots, whereas proteins overrepresented in WT or ∆AbcR1 are green or red, respectively. Overall, 68 proteins were affected by the presence of AbcR1, indicating potential targets of AbcR1 ([Table S1](#SUP1){ref-type="supplementary-material"}). Twenty-five were up and 43 downregulated. Twenty candidates were extracted from the gel, digested with trypsin, and subjected to mass spectrometry ([Table 1](#T1){ref-type="table"}). The presence of the known targets Atu2422 and Atu1879 among them validated this approach. Northern blot experiments revealed that the increased protein levels in the ∆AbcR1 mutant correlated with increased mRNA levels of *atu2422* and *atu1879* in stationary phase ([Fig. 1A and B](#F1){ref-type="fig"}).

###### **Table 1.** Potential AbcR1 targets in *A. tumefaciens* identified by 2D proteomics

  Protein   Locus tag   Product                                                              ∆AbcR1/WT
  --------- ----------- -------------------------------------------------------------------- -----------
  Atu4577   *atu4577*   ABC transporter substrate binding protein                            66,90
  PykA      *atu3762*   pyruvate kinase                                                      36,86
  RbsB      *atu3821*   ABC transporter substrate-binding protein (ribose)                   25,64
  Atu0857   *atu0857*   oxidoreductase                                                       13,45
  Atu2188   *atu2188*   oxidoreductase                                                       9,42
  MalE      *atu2601*   ABC transporter, substrate binding protein (maltose)                 8,05
  Pgi       *atu0404*   glucose-6-phosphate isomerase                                        6,64
  Atu4046   *atu4046*   ABC transporter substrate-binding protein (glycine betaine)          6,22
  MurE      *atu2099*   UDP-N-acetylmuramoylalanyl-D-glutamate-2,6- diaminopimelate ligase   5,87
  Atu1879   *atu1879*   ABC transporter, substrate binding protein (amino acid)              4,50
  Atu0157   *atu0157*   ABC transporter, substrate binding protein                           3,87
  Atu4678   *atu4678*   ABC transporter substrate-binding protein (amino acid)               3,85
  Atu2422   *atu2422*   ABC transporter, substrate binding protein (amino acid GABA)         3,66
  FrcB      *atu0063*   ABC transporter, substrate binding protein (sugar)                   2,13
  DppA      *atu4113*   ABC transporter substrate-binding protein (dipeptide)                2,07
                                                                                              
  Atu3259   *atu3259*   dehydrogenase                                                        0,20
  RplI      *atu1088*   50S ribosomal protein L9                                             0,18
  AtpH      *atu2625*   ATP Synthase delta chain                                             0,16
  MurB      *atu2092*   UDP-N-acetylenolpyruvoylglucosamine reductase                        0,08
  RplY      *atu2227*   50S ribosomal protein L25                                            0,05

List of proteins with altered abundance in three replicates of the ∆AbcR1 strain in comparison to the WT (fold changes \< 0.5 or \> 2, respectively). Quantitative proteomics was performed by two-dimensional PAGE with total protein samples from stationary growth phase (OD600: 1.5) of the *A*. *tumefaciens* wild-type (WT) and the AbcR1 deletion mutant (∆AbcR1) followed by MALDI-TOF analysis. The entire list of all proteins significantly accumulated in WT or in ∆AbcR1 can be found in [Figure S1](#SUP1){ref-type="supplementary-material"}.

![**Figure 1.** Identification of known AbcR1 targets by 2D-PAGE. Subsections of 2D gels showing Atu2422 (**A**) and Atu1879 (**B**) from *A*. *tumefaciens* WT (closed black circle) and ∆AbcR1 deletion mutant (dotted black circle) and northern blot analyses of *atu2422* (**B**) and *atu1879* (**C**) transcripts in different growth phases. The WT and the ∆AbcR1 deletion mutant (∆R1) were grown to exponential (OD600: 0.5) or stationary phase (OD600: 1.5) in YEB medium. Eight µg of total RNA were separated on 1.2% denaturing agarose gels. Ethidiumbromide-stained 16S rRNAs were used as loading control.](rna-11-624-g1){#F1}

Validation of eight new AbcR1 targets
-------------------------------------

The 18 other AbcR1-dependent proteins were so-far-unknown candidates ([Table S1](#SUP1){ref-type="supplementary-material"}). To recapitulate AbcR1-mediated regulation at the mRNA level, eight of the new candidates were chosen for northern blot analysis with *Agrobacterium* WT and ∆AbcR1 mutant grown to exponential (OD600 of 0.5) and stationary (OD600 of 1.5) phase. The mRNAs of five periplasmic binding proteins of ABC transporters (Atu4577, MalE, Atu4046, Atu4678, and DppA) showed clear AbcR1-dependent regulation consistent with elevated protein levels in the ∆AbcR1 strain ([Fig. 2A--E](#F2){ref-type="fig"}). The same was true for Atu0857, an annotated oxidoreductase ([Fig. 2F](#F2){ref-type="fig"}). The *frcB* transcript appears to be downregulated by AbcR1 in the exponential growth phase but, consistent with 2D PAGE, upregulated in stationary phase ([Fig. 2G](#F2){ref-type="fig"}). Reduced transcript levels of *atpH* in ∆AbcR1 in exponential growth supported positive regulation by AbcR1 as seen on the protein level ([Fig. 2H](#F2){ref-type="fig"}). Transcripts of *atpH* and *dppA* ([Fig. 2B](#F2){ref-type="fig"}) were only detectable in exponential growth phase suggesting that they undergo a rapid turnover in later growth phases.

![**Figure 2.** Validation of new AbcR1 targets. Subsections of 2D gels showing Atu4577 (**A**), MalE (**B**), Atu4046 (**C**), Atu4678 (**D**), DppA (**E**), Atu0857 (**F**), FrcB (**G**), and AtpH (**H**) from *A*. *tumefaciens* wild-type (closed black circles) and ∆AbcR1 mutant (dotted black circles) and corresponding northern blot analyses of target mRNAs in different growth phases. The wild-type (WT) and the ∆AbcR1 deletion mutant (∆R1) were grown and treated as in [Figure 1](#F1){ref-type="fig"}.](rna-11-624-g2){#F2}

Overlap between AbcR1- and Hfq-dependent mRNAs
----------------------------------------------

The AbcR1-dependent genes *malE*, *atu4678*, and *dppA* have recently been shown to be affected by Hfq.[@R61] In that study, several proteins overrepresented in the *A. tumefaciens hfq* mutant were isolated from 1D SDS-PAGE gels and identified as ABC transporters. This led us to assume that a more comprehensive profile of the ∆*hfq* proteome might reveal additional AbcR1 targets. Upon separation by 2D-SDS-PAGE, 31 putative Hfq-dependent proteins were selected and identified by mass spectrometry ([Fig. 3A](#F3){ref-type="fig"}). Among them were many periplasmic binding proteins of ABC transporters ([Table S2](#SUP1){ref-type="supplementary-material"}) and 10 proteins identified as AbcR1 targets were also affected by the absence of Hfq ([Fig. 3B](#F3){ref-type="fig"}) indicating that AbcR1 acts through Hfq as previously shown for the target Atu2422.[@R61]

![**Figure 3.** Altered protein synthesis in the ∆*hfq* mutant reveals new putative AbcR1 targets. (**A**) Total protein samples from stationary growth phase (OD600: 1.0) of *A*. *tumefaciens* WT and the *hfq* deletion mutant (∆*hfq)* were subjected to two-dimensional gel electrophoresis. Proteins overrepresented in WT or in ∆*hfq* preparations are shown in green or red, respectively. Proteins present in equal amounts in both preparations appear in yellow. Six (green spots) and 22 (red spots) proteins significantly accumulated equally in three replicates of WT (closed white circles) or in ∆*hfq* (dotted white circles) were analyzed via MALDI-TOF. Altered proteins that were not identified by MALDI-TOF are marked with numbers. \#, proteins were identified in multiple spots. (**B**) Venn diagram comparing altered proteins from different proteomic approaches (∆*hfq* 1D-gel, ∆*hfq* 2D-gel, and ∆AbcR1 2D-gel) in *A*. *tumefaciens*. ABC transporter components are underlined. (+) or (-) indicate over- or underrepresentation of proteins in deletion mutants.](rna-11-624-g3){#F3}

Validation of six more AbcR1 targets
------------------------------------

Northern blot experiments with probes against the two Hfq targets *atu4431* ([Fig. 3](#F3){ref-type="fig"}) and *atu4259* confirmed regulation by AbcR1 as their mRNAs accumulated in the sRNA mutant ([Fig. 4A and B](#F4){ref-type="fig"}; note that migration of the very abundant 16S rRNA to a similar position in the gel interferes with detection of the mRNAs and results in two bands).[@R61] One particularly interesting protein affected by Hfq was ChvE, a periplasmic sugar-binding protein involved in host sensing of *A*. *tumefaciens*.[@R43]^,^[@R45]^,^[@R64] Its regulatory pattern resembles that of FrcB. Both proteins were less abundant in the *hfq* deletion strain than in the WT ([Fig. 3A](#F3){ref-type="fig"}; [Table S2](#SUP1){ref-type="supplementary-material"}). In contrast to most other AbcR1 targets, but like the *frcB* transcript ([Fig. 2G](#F2){ref-type="fig"}), the *chvE* mRNA was slightly downregulated in the absence of AbcR1 in exponential phase but clearly upregulated in stationary phase ([Fig. 4C](#F4){ref-type="fig"}) suggesting growth phase-dependent regulation by AbcR1. Regulation of ChvE by AbcR1 raised our interest in NocT and AttC, substrate binding proteins of putative virulence-related ABC transporters required for the uptake of plant-synthesized nopaline (NocT) or for the transport spermidine and putrescine (AttC).[@R46] They were not detected by 2D PAGE analysis. However, northern blot analysis revealed that they clearly are AbcR1 targets. *nocT* is a typical negatively controlled AbcR1 target ([Fig. 4D](#F4){ref-type="fig"}) whereas regulation of *attC* varies depending on the growth condition ([Fig. 4E](#F4){ref-type="fig"}). The final potential AbcR1 target was predicted by the CopraRNA algorithm (Comparative Prediction Algorithm for sRNA Targets, see below).[@R8] Atu3114 was not identified by our proteomics approaches but northern blot analysis showed AbcR1-dependent regulation ([Fig. 4F](#F4){ref-type="fig"}).

![**Figure 4.** Verification of additional AbcR1 targets. Northern blot analyses of *atu4413* (**A**), *atu4259* (**B**), *chvE* (**C**), *nocT* (**D**), *attC* (**E**), and *atu3114* (**F**) mRNAs in different growth phases. The wild-type and the ∆AbcR1 deletion mutant (∆R1) were grown to exponential (OD600: 0.5) or stationary phase (OD600: 1.5) in YEB medium. Eight µg of total RNA were separated on 1.2% denaturing agarose gels. Ethidiumbromide-stained 16S rRNAs were used as loading control.](rna-11-624-g4){#F4}

CopraRNA predicts two functional AbcR1 modules and variable target-binding regions
----------------------------------------------------------------------------------

Having identified at least 16 AbcR1-dependent genes, we wondered whether they are all regulated by base pairing of the RBS with the first exposed loop of AbcR1 as documented for *atu2422* and *S. meliloti livK*.[@R26]^,^[@R57] To computationally predict interaction regions between AbcR1 and its target mRNAs, we made use of the recently established CopraRNA program.[@R8] It integrates phylogenetic information to predict sRNA--mRNA interactions on the genomic scale. An alignment of orthologous AbcR1 sequences from *A*. *tumefaciens* C58, *Agrobacterium radiobacter* K84, *Rhizobium etli* CFN42, *Rhizobium leguminosarum* bv. vicae, *Rhizobium etli* 652, *Sinorhizobium meliloti* 1021, and *Sinorhizobium medicae* WSM419 revealed long almost identical sequence stretches ([Fig. 5A](#F5){ref-type="fig"}). The secondary structures were compared using the ClustalW2 program prior to calculation of a consensus structure with the RNAalifold webserver.[@R65]^,^[@R66] Regions highly conserved in sequence are equally conserved in structure ([Fig. 5B](#F5){ref-type="fig"}). Like the experimentally mapped structure of *A. tumefaciens* AbcR1, the sRNAs fold into three hairpins.[@R26] Apart from the *atu2422* interaction site (module 1 = M1), a second conserved single-stranded region (M2) was found between the first and second hairpin. Both regions contain a UCCC motif potentially able to interact with SD-like sequences ([Fig. 5A and B](#F5){ref-type="fig"}). A domain prediction of putatively interacting sites between AbcR1 and 15 of the target mRNAs validated in this study (note that *atu4577* could not be used because it is not a conserved gene) suggested that both M1 and M2 are involved in target recognition ([Fig. 5C](#F5){ref-type="fig"}, for visualization of detailed AbcR1 M1- and M2-target mRNA interactions in *A*. *tumefaciens* see [Table S3](#SUP1){ref-type="supplementary-material"}). The predicted mRNA interaction sites preferentially lie around the SD sequence but several sites are located far into the coding region ([Fig. 5D](#F5){ref-type="fig"}; [Table S3](#SUP1){ref-type="supplementary-material"}).

![**Figure 5.** Comparative computational predictions suggest two functional AbcR1 modules. Sequence alignment (**A**) and consensus structure (**B**) of AbcR1 in *A*. *tumefaciens* C58 (*A*.*t*.), *A*. *radiobacter* K84 (*A*.*r*.), *R*. *etli* CFN42 (*R*.*e*.), *R*. *leguminosarum* bv. vicae (*R*.*l*.), *R*. *etli* 652 (*R*.*e*.652) *S*. *meliloti* 1021 (*S*.*m*.), and *S*. *medicae* WSM419 (*S*.*md*.). Sequence conservation is given in bold letters. Nucleotides highly conserved in structure are marked in red. The calculated structure is given in dot-bracket notation above the alignment. Grey shaded boxes (**A**) or gray marked nucleotides (**B**) represent regions M1 and M2. Visualization of the predicted binding regions in AbcR1 (**C**) and the experimentally verified targets of AbcR1 (**D**). The density plots at the top indicate the relative frequency of sRNA or mRNA nucleotide positions in the predicted AbcR1--target mRNA interactions. The density plots combine all optimal predictions for the 15 conserved verified targets in all included homologs of AbcR1 (**C**) or target mRNAs (**D**). Distinct interaction domains are indicated by local maxima marked with upright lines. Below the density plots, schematic alignments of the AbcR1 homologs (**C**) and the targets (**D**) are drawn to visualize the predicted optimal and suboptimal interactions for each organism. Each alignment contains eight lines, one for each organism included in the CopraRNA prediction. The order of the organisms in the alignment from top to bottom is: *A*. *tumefaciens* C58 (*A*.*t*.), *A*. *radiobacter* K84 (*A*.*r*.), *R*. *etli* CFN42 (*R*.*e*.), *R*. *leguminosarum* bv. vicae (*R*.*l*.), *R*. *etli* 652 (*R*.*e*.652) *S*. *meliloti* 1021 (*S*.*m*.), and *S*. *medicae* WSM419 (*S*.*md*.). The aligned regions are colored in gray and the optimal predicted interaction regions are given in different colors (for contrast only). The respective best suboptimal interaction site predictions are additionally shown by gray lines. White regions indicate gaps inside the AbcR1 alignment. Locus tag and gene name (if available) of target mRNAs are given on the right. A vertical gray line indicates the start codon. Numbering of bases in mRNA alignments is given relative to the start codon (**D**). For detailed visualization of optimal and suboptimal interactions for AbcR1 and its verified target mRNAs in *A*. *tumefaciens*, see [Table S3](#SUP1){ref-type="supplementary-material"}.](rna-11-624-g5){#F5}

AbcR1 discriminates between target mRNAs through two target-binding regions
---------------------------------------------------------------------------

A series of band shift experiments was used to experimentally validate the algorithmically predicted RNA--RNA interactions. Four different in vitro synthesized AbcR1 RNAs were used: the WT RNA, Mut1 with a UCC-AAA exchange in M1, Mut2 with a UCCC-AAAA exchange in M2, and the combined Mut1+2 exchange ([Fig. 6A](#F6){ref-type="fig"}). Band shift experiments were performed to verify interactions between AbcR1 variants and their target mRNAs. In the first round, the ^32^P-labeled AbcR1 variants were incubated with increasing concentrations of four different targets predicted to be addressed around the TIR. The target RNAs consisted of 100 to 150 nucleotides containing the predicted interaction region. As expected, band shifts with AbcR1 and AbcR1 Mut2 but not with the Mut1 and Mut1+2 RNAs confirmed complex formation between the TIRs of *atu2422* and *frcB* with AbcR1 region M1 ([Fig. 6B](#F6){ref-type="fig"}). Conversely, the *atu4678* and *chvE* TIRs were shown to interact with AbcR1 region M2 ([Fig. 6C](#F6){ref-type="fig"}).

![**Figure 6.** Binding of target mRNAs at the translation initiation region by two distinct functional modules. (**A**) Secondary structures of WT AbcR1 and the variants Mut1, Mut2, and Mut1+2. Band shift experiments with AbcR1 variants and *atu2422* (**B**), *frcB* (**B**), *atu4678* (**C**), *chvE* (**C**), and *atpH* (**D**) mRNA fragments (\~-50/+100 nt relative to the AUG start codon). Predicted IntaRNA duplexes formed by AbcR1 and target mRNAs are shown to the left. Numbering of mRNA nucleotides is given relative to the AUG/GUG start codon. ^32^P-labeled AbcR1 variants (\< 0.05 pmol) were incubated with increasing concentrations of unlabeled target RNAs at 30 °C for 20 min. Final concentrations of unlabeled RNA were added in 100 (lanes 2), 200 (lanes 3), and 400 (lanes 4) fold excess. Samples shown in lanes 1 were incubated with water (control).](rna-11-624-g6){#F6}

Underrepresentation of AtpH protein and *atpH* mRNA in the absence of AbcR1 ([Fig. 2H](#F2){ref-type="fig"}) suggested positive regulation by the sRNA. CopraRNA predicted an interaction between the TIR of *atpH* and AbcR1 region M2 including the adjacent hairpin 2 ([Figs. 5C and D](#F5){ref-type="fig"}). In agreement with this prediction, mutations in M1 or M2 alone and even in both M1 and M2 were not sufficient to fully abrogate AbcR1--*atpH* interaction suggesting an extended interaction ([Fig. 6D](#F6){ref-type="fig"}). The sRNA--mRNA interaction was lost in the simultaneous presence of a mutation in M2 of AbcR1 and in the *atpH* TIR (*atpH*-5U; [Fig. 6D](#F6){ref-type="fig"}).

In a second round of experiments, three mRNAs predicted to interact with AbcR1 in their CDS were tested. One hundred and fifty nt-long RNAs containing the predicted interaction region were incubated with the radiolabeled AbcR1 variants. Interaction of M1-containing AbcR1 in the CDS of *atu1879* ([Fig. 7A](#F7){ref-type="fig"}) explains why the TIR of *atu1879* could not be shifted in our previous study.[@R26] Region M1 also interacts with the CDS of *atu3114*. Extending the CopraRNA prediction, the CDS region of *malE* was not only able to interact with module M1 but also retarded the M2 RNA ([Fig. 7B](#F7){ref-type="fig"}) suggesting that both modules are able to initiate seed pairing. Consistent with this assumption, the Mut1+2 RNA was unable to shift the *malE* fragment.

![**Figure 7.** Binding of target mRNAs in the coding sequence by AbcR1. (Top) Secondary structures of AbcR1 wild-type, the variants Mut1, Mut2, and Mut1+2. Band shift experiments with AbcR1 variants and *atu1879* (**A**), *atu3114* (**A**), and *malE* (**B**) mRNA fragments (\~150 nt). Predicted IntaRNA duplexes formed by AbcR1 and target mRNAs are shown to the left. Numbering of mRNA nucleotides is given relative to the start codon. ^32^P-labeled AbcR1 variants (\< 0.05 pmol) were incubated with increasing concentrations of unlabeled target RNAs at 30 °C for 20 min. Final concentrations of unlabeled RNA were added in 100 (lanes 2), 200 (lanes 3) and 400 (lanes 4) fold excess. Samples from lanes 1 were incubated with water (control).](rna-11-624-g7){#F7}

In vivo verification of target binding by AbcR1 modules M1 and M2
-----------------------------------------------------------------

To validate the in vitro results on the interaction of AbcR1 with its target mRNAs in vivo, we used an *A*. *tumefaciens* ΔAbcR1/2 double mutant complemented with the empty vector (+v in [Fig. 8](#F8){ref-type="fig"}) or a plasmid constitutively expressing one of the four AbcR1 variants (+AbcR1, +Mut1, +Mut2, or +Mut1+2). Production of the AbcR1 transcripts was confirmed by northern blot analysis ([Fig. 8A](#F8){ref-type="fig"}). The mRNA levels of four different AbcR1 targets were determined by northern blot analysis. Consistent with the band shift experiments ([Figs. 6](#F6){ref-type="fig"} and [7](#F7){ref-type="fig"}), region M1 was responsible for regulation of *atu2422* and *atu3114* ([Fig. 8B and D](#F8){ref-type="fig"}). In accordance with the band shift results ([Fig. 6C](#F6){ref-type="fig"}), *atu4678* was predominantly controlled via M2 ([Fig. 8C](#F8){ref-type="fig"}). The same was true for *atu4431*, which was predicted to bind the M2 region AbcR1 in in its coding sequence ([Fig. 8E](#F8){ref-type="fig"}).

![**Figure 8.** In vivo validation of AbcR1 modules 1 and 2. Northern blot analyses of AbcR1 (**A**), *atu2422*(**B**), *atu4678*(**C**), *atu3114*(**D**), and *atu4431*(**E**) transcripts from cultures of the *A*. *tumefaciens*wild-type (WT) or the ΔAbcR1/2 deletion mutant (ΔR1/2) complemented with a plasmid expressing different AbcR1 variants (+R1, +Mut1, +Mut2, +Mut1+2). The strains were grown in YEB medium. +v: control strains harboring the empty vector. Eight μg of total RNA were separated on 1.2% denaturing agarose gels. Ethidiumbromide-stained tRNAs or 16S rRNAs were used as loading control.](rna-11-624-g8){#F8}

Binding sites of AbcR1 in the CDS contain SD-like sequences
-----------------------------------------------------------

To precisely map the AbcR1-binding positions in the CDS of selected target mRNAs, we used an in vitro reverse transcription approach. The principle is illustrated in [Figure 9A](#F9){ref-type="fig"}. Target mRNA fragments of 100 or 150 nt length were annealed to end-labeled primers complementary to regions upstream of the predicted interaction region followed by cDNA synthesis. Truncated products upon addition of two different concentrations of AbcR1 prior to reverse transcription were mapped in reference to a sequence reaction run on the same gel. In a control experiment ([Fig. 9B](#F9){ref-type="fig"}), the mapped *atu2422*--AbcR1 interaction site corresponded to the previously reported site overlapping the SD sequence of the mRNA.[@R26] As an example for an mRNA targeted far within the CDS, *atu3114* was used. The CopraRNA-predicted region around 516 nt in the open reading frame was found to interact with AbcR1, thus resulting in prematurely terminated cDNA fragments ([Fig. 9C](#F9){ref-type="fig"}). With the *malE* RNA, the presence of AbcR1 led to truncated cDNA products corresponding to a CDS region around +207 ([Fig. 9D](#F9){ref-type="fig"}). The mapped interactions sites show that AbcR1 addresses SD-like UGGGAG motifs (see sequence to the left of [Fig. 9B--D](#F9){ref-type="fig"}) regardless of their position in the mRNA.

![**Figure 9.** Precise mapping of AbcR1 binding sites in target mRNAs. (**A**) Principle of AbcR1 binding-site mapping by toeprinting analysis. -AbcR1, without AbcR1; reverse transcription (RT) starting from a primer complementary to the target mRNA sequence transcribes a full-length product. +AbcR1, pairing of AbcR1 with the target sequence terminates reverse transcription (truncated product). AbcR1 binding-site mapping on *atu2422* (**B**), *atu3114* (**C**), and *malE* (**D**) RNA fragments was performed as described in *Experimental procedures*. The position of truncated products is indicated to the right. mRNA nucleotides involved in M1 binding are shown to the left. Concentrations of AbcR1 RNAs were 1.5 pmol µl^−1^ (lane 2) and 2.5 pmol µl^−1^ (lane 3).](rna-11-624-g9){#F9}

AbcR1 promotes degradation of target mRNAs when bound to the TIR or CDS
-----------------------------------------------------------------------

The previously identified target mRNAs of *atu2422* and *atu1879* were significantly stabilized in the absence of AbcR1 in vivo.[@R26] This provided evidence that interaction of M1 with the TIR (*atu2422*) or CDS (*atu1879*) accelerates mRNA turnover and led us to study the effect of AbcR1 on the stability of various target mRNAs. We selected one example each for M1-TIR, M2-TIR, M1-CDS, M2-TIR, and M1/M2-CDS interactions and determined mRNA degradation in the presence or absence of AbcR1 after transcription was stopped by addition of rifampicin.

Interaction of AbcR1 with the TIR via M1 (*frcB*, [Fig. 10A](#F10){ref-type="fig"}) or M2 (*atu4678*, [Fig. 10B](#F10){ref-type="fig"}) destabilizes the target mRNAs as shown by their elevated stability in the absence of the sRNA. The same is true when the CDS is bound by AbcR1 either by M1 (*atu3114*, [Fig. 10C](#F10){ref-type="fig"}), M2 (*atu4431*, [Fig. 10D](#F10){ref-type="fig"}), or M1 or M2 (*malE*, [Fig. 10E](#F10){ref-type="fig"}) suggesting that negative regulation by AbcR1 involves RNA degradation regardless of whether the TIR or CDS is targeted. Contrary to these negatively regulated transcripts, stability of the positively regulated *atpH* transcripts was not influenced by AbcR1 ([Fig. 10F](#F10){ref-type="fig"}).

![**Figure 10.** AbcR1 M1 and M2 target mRNAs in the TIR and the CDS for degradation. Northern blot analyses of *frcB*(**A**), *atu4678*(**B**), *atu3114*(**C**), *atu4431*(**D**), *malE*(**E**), and *atpH*(**F**) transcripts from cultures treated with rifampicin. Cultures of the *A*. *tumefaciens*wild-type (WT) or the ΔAbcR1 deletion mutant (ΔR1) were grown to exponential or stationary (in case of *frcB*) growth phase in YEB medium and treated with rifampicin (250 mg ml^-1^). Total RNA fractions were collected at the indicated time points. Eight μg of total RNA were separated on 1.2% denaturing agarose gels. Ethidiumbromide-stained 16S rRNAs were used as loading control. Quantification of transcript stabilities and their calculated half-lives are given to the right.](rna-11-624-g10){#F10}

Discussion
==========

Global approaches like proteomics or microarrays and bioinformatic predictions are commonly used for sRNA target identification.[@R2]^,^[@R8]^,^[@R67] In this study, we employed a combination of global proteomics and comparative biocomputational predictions for identifying targets of AbcR1 in the plant-pathogen *A*. *tumefaciens*. Validation of 14 targets via northern blot hybridization enlarged the set of currently known AbcR1 targets to 16 mRNAs. Although several target mRNAs of AbcR1 have been reported in *Brucella* and *Sinorhizobium*, the mode of action of this conserved sRNA has not yet been studied.[@R57]^,^[@R59] Our study uncovered two distinct target-binding sites in AbcR1 and variable interacting loci in the controlled transcripts.

AbcR1 targets different sites of mRNAs through two functional modules
---------------------------------------------------------------------

Many Hfq-associated sRNAs contain one single-stranded domain able to interact with multiple target mRNAs.[@R5]^,^[@R14]^,^[@R68]^-^[@R71] Other sRNAs have several functional domains that base pair with different sets of target mRNAs in *E*. *coli*, *Salmonella*, and *Vibrio harveyi*.[@R7]^,^[@R16]^,^[@R72]^,^[@R73]

Previously, only one conserved target-binding region strategically positioned in the first exposed hairpin loop of AbcR1 has been reported.[@R26]^,^[@R59] Here, we exploited the recently established comparative target prediction tool CopraRNA, which has been previously used to predict the two and three interaction regions of GcvB and Spot42, respectively.[@R7]^,^[@R8]^,^[@R73] Strikingly, the two computationally predicted and experimentally verified modules M1 and M2 are highly conserved among *Rhizobiaceae* suggesting that the two functional modules are not limited to AbcR1 in *A*. *tumefaciens*. The more distantly related AbcR1 sequence from *Brucella* was not included in the CopraRNA predictions because it exhibits less sequence identity to *A*. *tumefaciens* AbcR1 than the homologs from *Sinorhizobium* and *Rhizobium* species. The existence of two single-stranded M1- and M2-like regions in the predicted secondary structure of *B*. *abortus* AbcR1, however, suggests that two functional AbcR1 modules are not restricted to plant-associated bacteria.[@R59]

On the target site, our study revealed that AbcR1 binding regions are scattered throughout the TIR and CDS. Although interference with translation by mRNA binding around the SD sequence is considered the most common control mechanism of sRNAs, targeting of coding sequences has been described in enterobacteria, for example, MicC and *ompD*, ArcZ-*tpx*, RybB-*fadL*, SgrS-*manX*, and SdsR-*ompD*.[@R14]^,^[@R71]^,^[@R74]^-^[@R76] Two exposed UC-rich interaction regions in AbcR1 and the potential to interact with SD-like regions in the TIR or CDS allows pervasive gene regulation by this sRNA in *A. tumefaciens*.

AbcR1: A conserved master regulator of ABC transporters
-------------------------------------------------------

There is increasing evidence that sRNAs are more than single target regulators, but rather act on multiple *trans*-encoded targets and rewire entire transcriptional networks.[@R2]^,^[@R77]^,^[@R78] Many well-studied sRNAs in enterobacteria control large sets of functionally related target mRNAs; for example, RyhB regulates mRNAs encoding iron-binding proteins involved in iron homeostasis, OmrA/OmrB regulate mRNAs encoding proteins for outer membrane protein synthesis, and GcvB controls genes for amino acid biosynthesis and transport.[@R7]^,^[@R22]^-^[@R24]^,^[@R69]^,^[@R70]^,^[@R79]^-^[@R83]

Homologs of AbcR1 from *S*. *meliloti*, *R*. *etli*, and *B*. *abortus* are similar in sequence and structure.[@R52]^-^[@R54]^,^[@R56]^,^[@R59]^,^[@R84] A functional classification of target mRNAs (ABC transport system) was initially described for the AbcR sRNAs in *A*. *tumefaciens* and *B*. *abortus* 2308.[@R26]^,^[@R59] The experimental verification of 14 AbcR1 targets encoding periplasmic transport proteins carrying sugars, amino acids, and opines supports the function of AbcR1 as a key regulator for these transport systems ([Fig. 11](#F11){ref-type="fig"}).

![**Figure 11.** The AbcR1 regulon of *A*. *tumefaciens*. AbcR1 controls mRNAs of periplasmic substrate-binding proteins of 14 ABC transporters (sugars and amino acids to the left and right, respectively), an annotated oxidoreductase (*atu0857*) and AtpH. Module 1 (red) and module 2 (blue) dependent genes are sorted toward the top and bottom of the schematic cell, respectively. The interaction region (TIR or CDS) and the mode of action (repression or activation) are indicated. Dashed lines refer to computationally predicted interactions.](rna-11-624-g11){#F11}

Our previous study described a potential role of AbcR1 in plant defense, quorum sensing, and virulence of *A*. *tumefaciens* because the AbcR1 target *atu2422* codes for binding protein of an importer of GABA, a plant defense molecule.[@R26]^,^[@R85]^-^[@R88] We now find that AbcR1 also silences synthesis of ChvE ([Fig. 4C](#F4){ref-type="fig"}), a regulator in sugar-dependent activation of the virulence cascade as well as other virulence-related ABC transporters (NocT and AttC).[@R43]^,^[@R45] This strengthens the hypothesis that AbcR1 is involved in plant--microbe interactions and post-infection nutrient acquisition.

Although most currently known sRNAs block translation of target mRNAs by interfering with ribosome binding, several sRNAs can activate gene expression.[@R89] They can, for example, bind upstream of the TIR and remodel an intrinsic inhibitory mRNA structure such that the sequestered ribosome binding site is liberated (DsrA and RprA).[@R90]^-^[@R92] Recently, new translation-independent pathways of mRNA activations have been reported for *cfa* through RydC and for *yigL* through SgrS in *Salmonella*.[@R19]^,^[@R93] In enterobacteria, well-characterized sRNAs like RyhB and ArcZ repress some target mRNAs, but activate translation of *shiA* (RyhB) and *rpoS* (ArcZ).[@R69]^,^[@R74]^,^[@R79]^,^[@R80]^,^[@R94] In addition to the many negatively controlled AbcR1 targets in *A. tumefaciens* we found *atpH* as positively regulated gene. It is predicted to encode the delta subunit of the ATP synthase. In *E*. *coli*, this subunit plays a key role in the assembly of the H^+^-translocating F~0~F~1~ ATP synthase.[@R95] Although it remains unknown how AbcR1 controls *atpH* expression, for instance, AbcR1 does not alter *atpH* mRNA stability directly, the extensive interaction region between AbcR1 M2 and the TIR of *atpH* is indicative of a direct mechanism. Control of multiple ABC transporters and the ATP synthase suggests that AbcR1 coordinates nutrient acquisition and energy conversion in *A. tumefaciens*.

Experimental Procedures
=======================

Bacterial growth conditions
---------------------------

Bacterial strains and antibiotics used in this study are listed in [Table S5](#SUP1){ref-type="supplementary-material"}. *E*. *coli* was grown in LB medium at 37 °C. *A*. *tumefaciens* strains were cultivated in YEB medium at 30 °C.

Strain and vector constructions
-------------------------------

The ∆AbcR1 and ∆*hfq* mutant strains were constructed in previous studies.[@R26]^,^[@R61] Runoff plasmids as templates for in vitro transcription of AbcR1 or target mRNA fragments were flanked by the T7-promoter sequence (GAAATTAATA CGACTCACTA TAGGG) and an *Eco*RV site PCR-amplified with primers listed in [Table S4](#SUP1){ref-type="supplementary-material"} and subcloned into pUC18.[@R96] AbcR1 variants were constructed via site-directed mutagenesis using the primers listed in [Table S4](#SUP1){ref-type="supplementary-material"}.

Protein preparation
-------------------

Cells of *A*. *tumefaciens* wild-type, ∆AbcR1, and ∆*hfq* were grown in 30 ml YEB medium at 30 °C to an OD600 of 1.5. Culture volumes of 30 ml were harvested, washed three times in 30 ml of TE-buffer (100 mM Tris and 1 mM EDTA), and finally resuspended in 4 ml of TE-buffer with 1.39 mM PMSF and 0.2 mM DTT. Cells were disrupted by three passes through a chilled French press. The lysates were centrifuged at 10 000 × g for 30 min to remove the cell debris. Protein concentrations were determined by Bradford assays.[@R97]

Two-dimensional PAGE and Mass Spectrometry
------------------------------------------

Total proteins extracts of *A*. *tumefaciens* wild-type, ∆AbcR1, and ∆*hfq* cells were concentrated by chloroform/methanol precipitation up to 600 μg μl−1.[@R98] Isoelectric focusing and SDS-PAGE were performed as described previously.[@R99] Protein solutions were loaded on Immobiline DryStrip pH 4--7, 24 cm (GE Healthcare). After isoelectric focusing, proteins were subjected to 12.5% SDS-PAGE, and the spots were visualized using RuBPS (C~72~H~42~N~6~Na~4~O~18~RuS~6~) staining. Protein spots were scanned using a Typhoon TRIO (GE Healthcare) and were quantified with the Delta two-dimensional software (version 4.0, Decodon). Selected protein spots were excised from the gel, and protein identification using mass spectrometry was performed by MALDI-TOF mass spectrometry as described previously.[@R100]

RNA preparation and northern analysis
-------------------------------------

Cells were harvested, washed, and frozen in liquid nitrogen as described previously.[@R26] Isolation of total RNA was done by using the hot acid phenol method.[@R101] Northern analyses were performed as previously described.[@R26] To measure mRNA stability, rifampicin was added to the cell cultures in a final concentration of 250 mg ml^−1^ and samples for RNA isolation were collected before (0 min) and 1, 2, 3, 4, and 6 min after addition of the transcriptional inhibitor rifampicin. In order to determine the half-life of the specific mRNAs, the amount of transcripts present at each time point was quantified using the Image software Alpha Ease FC (Alpha Innotech). The primers used for RNA probe generation are listed in [Table S4](#SUP1){ref-type="supplementary-material"} in the supplemental material.

Gel shift experiments
---------------------

The sRNAs AbcR1 WT, QC1, QC2, and QC1+2 and the target mRNA fragments (comprising \~150 nucleotides in the TIR or in the CDS) were synthesized in vitro by runoff transcription with T7 RNA polymerase from the linearized plasmids listed in [Table S4](#SUP1){ref-type="supplementary-material"}. 5' end labeling of AbcR1 WT or AbcR1 variants (QC1, QC2, and QC1+2) with ^32^P was performed as described.[@R102] RNA band shift experiments were performed in 1x structure buffer (Ambion) in a total reaction mixture volume of 15 µl as follows. 5′ end labeled AbcR1 (corresponding to 5000 c.p.m.) and 1 µg of tRNA were incubated in the presence of unlabeled target mRNA fragments (\~150 nt) at 30 °C for 20 min. The final concentrations of added unlabeled RNA fragments are given in the figure legends. Prior to gel loading, the binding reactions were mixed 4.5 µl of native loading dye (50% glycerol, 0.5× TBE, 0.1% bromophenol blue and 0.1% xylene cyanol) and run on native 6% polyacrylamide gels in 0.5× TBE buffer at 300 V for 1.5--3 h.

Mapping of sRNA-binding sites
-----------------------------

Mapping of AbcR1-binding sites were performed like previously described "toeprint analysis" with some modifications.[@R103] Annealing mixtures contained 0.5 pmol unlabeled *atu2422* (50 nt +/− from the AUG start codon), *malE* (+100/+250 relative to AUG start codon), or *atu3114* (+437/+588 relative to AUG start codon) mRNA fragments and 1 pmol of 5′ end labeled primer runoff\_*atu2422*\_rv, runoff\_*malE2*\_rv, and runoff\_*atu3114*\_rv in VD buffer without magnesium. Annealing mixtures were heated for 3 min at 80 °C and snap frozen in a frozen plastic box. After incubation on ice for 20 min, different concentrations (listed in figure legends) of AbcR1, WT, or water (as negative control) were added and incubated at 37 °C for 20 min. After addition of 2 µl MMLV-Mix (VD + Mg^2+^, BSA, dNTPs and MMLV reverse transcriptase \[USB\]), cDNA synthesis were performed at 37 °C for 10 min. Reactions were stopped by adding formamide loading dye and reaction aliquots were separated on a denaturing 8% polyacrylamide gel. Reverse transcription cDNA products were identified by comparison with sequences generated with the same 5′ end labeled primer.

Bioinformatic tools
-------------------

Alignments of sequences were generated by the ClustalW software obtained from <http://www.ebi.ac.uk/Tools/msa/clustalw2/>. sRNA--mRNA duplexes were predicted by the IntaRNA webserver from <http://rna.informatik.uni-freiburg.de:8080/v1/IntaRNA.jsp>.[@R104] Secondary structures and consensus structures were computed with mfold <http://mfold.rna.albany.edu/?q=mfold/RNA-Folding-Form> and RNAalifold <http://rna.tbi.univie.ac.at/cgi-bin/RNAalifold.cgi>.[@R65]^,^[@R105] Comparative predictions for AbcR1 binding sites and targets were done with CopraRNA http://rna.informatik.uni-freiburg.de/CopraRNA/Input.jsp
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